Skip to content
TrialScanner

NCT01968213

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Phase 3CompletedMYGNCollaborator

Registry record

Lead sponsor
pharmaand GmbH
Conditions
Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Primary completion
Apr 1, 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01968213 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01968213: Phase 3 Study of Rucaparib... | TrialScanner